Trade BLLN anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
BillionToOne, Inc. Class A (BLLN) is trading at US$93.24, down 2.01% today as of Aug 28, 16:00 EDT. The company has a market capitalisation of US$4.48B. Over the past 52 weeks, BLLN has traded between US$61.96 and US$150.44. On Syfe you can trade BLLN with $0 commission and add it to your watchlist.
| Previous close | US$95.15 |
|---|---|
| Market cap | US$4.48B |
| P/E ratio | 97.74 |
| 52-week range | US$61.96 – US$150.44 |
| Volume | 423.07K |
| Exchange | US |
Add to Watchlist
Set Price Alert
BillionToOne, Inc. Class A
BillionToOne, Inc. is a next-generation molecular diagnostics company on a mission to create powerful and accurate tests that are accessible to all. Its patented Quantitative Counting Templates (QCT) molecular counting platform is a multiplex technology capable of accurately counting DNA molecules at the single-molecule level. The was founded by Oguzhan Atay, Sukrit Silas, and David Tsao in 2016 and is headquartered in Menlo Park, CA.
Year: 2025
BillionToOne, Inc. Class A (BLLN) stock is trading at US$93.24, -2.01% from the previous close of US$95.15.
The market cap for BillionToOne, Inc. Class A (BLLN) stock is approximately US$4.48B.
The price-to-earnings ratio for BillionToOne, Inc. Class A (BLLN) is 97.74, based on the latest reported earnings.
The 52-week high for BillionToOne, Inc. Class A (BLLN) stock is US$150.44.
The 52-week low for BillionToOne, Inc. Class A (BLLN) stock is US$61.96.
BillionToOne, Inc. Class A (BLLN) does not currently pay a dividend.
Stay on top of BLLN
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
